Cascadian Therapeutics, Inc.
Mailing Address: 2601-4th Avenue
Suite 500
Seattle, Washington
Head Office Address: 2601 - 4th Avenue
Suite 500
Seattle, Washington
Contact Name: Julie Rathbun Principal Regulator: Alberta
Business e-mail address: Short Form Prospectus Issuer: No
Telephone Number: 206 801-2100 Reporting Jurisdictions: Ceased Reporting
Fax Number: 206 801-2101 Stock Exchange: N/A
Date of Formation: Sep 7 2007 Stock Symbol:
Jurisdiction Where Formed: Delaware Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 14740B Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000

View This Company's Documents